Report Detail
COVID-19 Impact on Global Oncology Generic Injectable Drugs Market Insights, Forecast to 2026
- RnM3984965 |
- 03 June, 2020 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Generic drugs are essential in oncology because some anticancer drugs are only available as generics.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Oncology Generic Injectable Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Oncology Generic Injectable Drugs industry.
Based on our recent survey, we have several different scenarios about the Oncology Generic Injectable Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Oncology Generic Injectable Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Generic Injectable Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncology Generic Injectable Drugs market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Oncology Generic Injectable Drugs market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Sales and Pricing Analyses
Readers are provided with deeper sales analysis and pricing analysis for the global Oncology Generic Injectable Drugs market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Oncology Generic Injectable Drugs market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Oncology Generic Injectable Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncology Generic Injectable Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncology Generic Injectable Drugs market.
The following manufacturers are covered in this report:
Teva Pharmaceutical
Pfizer
AstraZeneca
Roche
Eli Lilly
GlaxoSmithKline
Novartis
Mylan
Natco Pharma
Oncology Generic Injectable Drugs Breakdown Data by Type
Large Molecule Drugs
Small Molecule Drugs
Oncology Generic Injectable Drugs Breakdown Data by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
1 Study Coverage
- 1.1 Oncology Generic Injectable Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Oncology Generic Injectable Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Oncology Generic Injectable Drugs Market Size Growth Rate by Type
- 1.4.2 Large Molecule Drugs
- 1.4.3 Small Molecule Drugs
- 1.5 Market by Application
- 1.5.1 Global Oncology Generic Injectable Drugs Market Size Growth Rate by Application
- 1.5.2 Hospital Pharmacies
- 1.5.3 Retail Pharmacies
- 1.5.4 Online Pharmacies
- 1.6 Coronavirus Disease 2019 (Covid-19): Oncology Generic Injectable Drugs Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Oncology Generic Injectable Drugs Industry
- 1.6.1.1 Oncology Generic Injectable Drugs Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Oncology Generic Injectable Drugs Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Oncology Generic Injectable Drugs Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Oncology Generic Injectable Drugs Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Executive Summary
- 2.1 Global Oncology Generic Injectable Drugs Market Size Estimates and Forecasts
- 2.1.1 Global Oncology Generic Injectable Drugs Revenue 2015-2026
- 2.1.2 Global Oncology Generic Injectable Drugs Sales 2015-2026
- 2.2 Oncology Generic Injectable Drugs Market Size by Region: 2020 Versus 2026
- 2.2.1 Global Oncology Generic Injectable Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Oncology Generic Injectable Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oncology Generic Injectable Drugs Competitor Landscape by Players
- 3.1 Oncology Generic Injectable Drugs Sales by Manufacturers
- 3.1.1 Oncology Generic Injectable Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Oncology Generic Injectable Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Oncology Generic Injectable Drugs Revenue by Manufacturers
- 3.2.1 Oncology Generic Injectable Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Oncology Generic Injectable Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Oncology Generic Injectable Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Oncology Generic Injectable Drugs Revenue in 2019
- 3.2.5 Global Oncology Generic Injectable Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Oncology Generic Injectable Drugs Price by Manufacturers
- 3.4 Oncology Generic Injectable Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Oncology Generic Injectable Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Oncology Generic Injectable Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Oncology Generic Injectable Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Oncology Generic Injectable Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Oncology Generic Injectable Drugs Sales by Type (2015-2020)
- 4.1.2 Global Oncology Generic Injectable Drugs Revenue by Type (2015-2020)
- 4.1.3 Oncology Generic Injectable Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Oncology Generic Injectable Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Oncology Generic Injectable Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Oncology Generic Injectable Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Oncology Generic Injectable Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Oncology Generic Injectable Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
- 5.1 Global Oncology Generic Injectable Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Oncology Generic Injectable Drugs Sales by Application (2015-2020)
- 5.1.2 Global Oncology Generic Injectable Drugs Revenue by Application (2015-2020)
- 5.1.3 Oncology Generic Injectable Drugs Price by Application (2015-2020)
- 5.2 Oncology Generic Injectable Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Oncology Generic Injectable Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Oncology Generic Injectable Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Oncology Generic Injectable Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Oncology Generic Injectable Drugs by Country
- 6.1.1 North America Oncology Generic Injectable Drugs Sales by Country
- 6.1.2 North America Oncology Generic Injectable Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Oncology Generic Injectable Drugs Market Facts & Figures by Type
- 6.3 North America Oncology Generic Injectable Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Oncology Generic Injectable Drugs by Country
- 7.1.1 Europe Oncology Generic Injectable Drugs Sales by Country
- 7.1.2 Europe Oncology Generic Injectable Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Oncology Generic Injectable Drugs Market Facts & Figures by Type
- 7.3 Europe Oncology Generic Injectable Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Oncology Generic Injectable Drugs by Region
- 8.1.1 Asia Pacific Oncology Generic Injectable Drugs Sales by Region
- 8.1.2 Asia Pacific Oncology Generic Injectable Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Oncology Generic Injectable Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Oncology Generic Injectable Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Oncology Generic Injectable Drugs by Country
- 9.1.1 Latin America Oncology Generic Injectable Drugs Sales by Country
- 9.1.2 Latin America Oncology Generic Injectable Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Oncology Generic Injectable Drugs Market Facts & Figures by Type
- 9.3 Central & South America Oncology Generic Injectable Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Oncology Generic Injectable Drugs by Country
- 10.1.1 Middle East and Africa Oncology Generic Injectable Drugs Sales by Country
- 10.1.2 Middle East and Africa Oncology Generic Injectable Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Oncology Generic Injectable Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Oncology Generic Injectable Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Teva Pharmaceutical
- 11.1.1 Teva Pharmaceutical Corporation Information
- 11.1.2 Teva Pharmaceutical Description, Business Overview and Total Revenue
- 11.1.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Teva Pharmaceutical Oncology Generic Injectable Drugs Products Offered
- 11.1.5 Teva Pharmaceutical Recent Development
- 11.2 Pfizer
- 11.2.1 Pfizer Corporation Information
- 11.2.2 Pfizer Description, Business Overview and Total Revenue
- 11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Pfizer Oncology Generic Injectable Drugs Products Offered
- 11.2.5 Pfizer Recent Development
- 11.3 AstraZeneca
- 11.3.1 AstraZeneca Corporation Information
- 11.3.2 AstraZeneca Description, Business Overview and Total Revenue
- 11.3.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 AstraZeneca Oncology Generic Injectable Drugs Products Offered
- 11.3.5 AstraZeneca Recent Development
- 11.4 Roche
- 11.4.1 Roche Corporation Information
- 11.4.2 Roche Description, Business Overview and Total Revenue
- 11.4.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Roche Oncology Generic Injectable Drugs Products Offered
- 11.4.5 Roche Recent Development
- 11.5 Eli Lilly
- 11.5.1 Eli Lilly Corporation Information
- 11.5.2 Eli Lilly Description, Business Overview and Total Revenue
- 11.5.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Eli Lilly Oncology Generic Injectable Drugs Products Offered
- 11.5.5 Eli Lilly Recent Development
- 11.6 GlaxoSmithKline
- 11.6.1 GlaxoSmithKline Corporation Information
- 11.6.2 GlaxoSmithKline Description, Business Overview and Total Revenue
- 11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 GlaxoSmithKline Oncology Generic Injectable Drugs Products Offered
- 11.6.5 GlaxoSmithKline Recent Development
- 11.7 Novartis
- 11.7.1 Novartis Corporation Information
- 11.7.2 Novartis Description, Business Overview and Total Revenue
- 11.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Novartis Oncology Generic Injectable Drugs Products Offered
- 11.7.5 Novartis Recent Development
- 11.8 Mylan
- 11.8.1 Mylan Corporation Information
- 11.8.2 Mylan Description, Business Overview and Total Revenue
- 11.8.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Mylan Oncology Generic Injectable Drugs Products Offered
- 11.8.5 Mylan Recent Development
- 11.9 Natco Pharma
- 11.9.1 Natco Pharma Corporation Information
- 11.9.2 Natco Pharma Description, Business Overview and Total Revenue
- 11.9.3 Natco Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Natco Pharma Oncology Generic Injectable Drugs Products Offered
- 11.9.5 Natco Pharma Recent Development
- 11.1 Teva Pharmaceutical
- 11.1.1 Teva Pharmaceutical Corporation Information
- 11.1.2 Teva Pharmaceutical Description, Business Overview and Total Revenue
- 11.1.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Teva Pharmaceutical Oncology Generic Injectable Drugs Products Offered
- 11.1.5 Teva Pharmaceutical Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Oncology Generic Injectable Drugs Market Estimates and Projections by Region
- 12.1.1 Global Oncology Generic Injectable Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Oncology Generic Injectable Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Oncology Generic Injectable Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Oncology Generic Injectable Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Oncology Generic Injectable Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Oncology Generic Injectable Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Oncology Generic Injectable Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Oncology Generic Injectable Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Oncology Generic Injectable Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Oncology Generic Injectable Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Oncology Generic Injectable Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Oncology Generic Injectable Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Oncology Generic Injectable Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Oncology Generic Injectable Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Oncology Generic Injectable Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Oncology Generic Injectable Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Oncology Generic Injectable Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Oncology Generic Injectable Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Oncology Generic Injectable Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Oncology Generic Injectable Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Oncology Generic Injectable Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Oncology Generic Injectable Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter’s Five Forces Analysis
- 13.5 Primary Interviews with Key Oncology Generic Injectable Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Oncology Generic Injectable Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Oncology Generic Injectable Drugs. Industry analysis & Market Report on COVID-19 Impact on Global Oncology Generic Injectable Drugs is a syndicated market report, published as COVID-19 Impact on Global Oncology Generic Injectable Drugs Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Oncology Generic Injectable Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
